CLNK B, CELLINK B, (SE0013647385) Trading; Overview; Performance; Key Ratios; Financials; Fact Sheet ; Company Fact Sheet FAQ & Methodology

Access detailed information about the Cellink AB (CLNKb) Share including Price, Charts, Technical Analysis, Historical data, Cellink Reports and more.

Under the agreement, Cellink AB is set to acquire all shares for a purchase price on cash- and debt-free basis of €70m. Cellink är ett bioteknikbolag. Bolaget har utvecklat 3D bioskrivare som möjliggör en utveckling och produktion av mänsklig vävnad. En stor del av verksamheten baseras på forskning och utveckling inom området. Kunderna återfinns bland Life Science bolag, samt bland andra forskare och aktörer inom branschen. Stockholm, April 20, 2020 – Nasdaq (Nasdaq: NDAQ) announces that the trading in Cellink AB’s shares (short name: CLNK B) will commence today on the Nasdaq Stockholm main market.

Time. Files. IPO · Type. Price. Pre-money.

2021-04-13 · CLNKB:Stockholm Stock Quote - CELLINK AB - Bloomberg Markets.

A-aktien har ticker STAR A och Hoppa till Cellink stock symbol. YRCW Aktiekurs SVENSKA CELLULOSA Sverigetaxi i Stockholm AB.Created

Its products allow researchers to 3D print human organs and tissues for the development of pharmaceutical and cosmetic products and for clinical applications. The company's technology is used to print tissues 03/15. CELLINK : launches the BIO MDX Series , a scaled-up revolution in biomedical manufacturing. AQ. 03/12.

CELLINK AB (publ) ('CELLINK' or the 'Company') hereby announces its intention to carry out directed share issues of series B shares corresponding to approximately 13.5 percent of the total number o

CELLINK AB (”CELLINK” or “the Company”) today announces that the Company intends to carry out a directed new share issue, pursuant to an authorization granted b Cellink AB announces an offering of Senior Unsecured Convertible Bonds The conversion price is expected to be set at a premium of between 40.0% and 45.0% above the reference share price, CELLINK AB (publ) ('CELLINK' or the 'Company') hereby announces its intention to carry out directed share issues of series B shares corresponding to approximately 13.5 percent of the total number o Shareholders of Cellink AB (publ) will be pleased this week, given that the stock price is up 16% to kr115 following its latest quarterly results.Revenues of kr46m crushed expectations, although expenses also blew out, with the company reporting a statutory loss per share of kr0.53, 61% bigger than analysts expected. Cellink AB will take over all shares of Ginolis Oy, a Finnish company focusing on diagnostics automation and advanced robotics solutions for medical and diagnostic industries. Under the agreement, Cellink AB is set to acquire all shares for a purchase price on cash- and debt-free basis of €70m. Cellink är ett bioteknikbolag.

At the current price of SEK480.6, shares in Cellink AB are trading at 0.110k% against their 200 day moving average. CLNK.B | Complete Cellink AB Series B stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. View the latest Cellink AB Series B (CLNK.B) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get the latest Cellink AB (CLNK-B) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Syva bar

September 7, 2020 CELLINK have been granted funding totalling â‚¬3,910,000 from the EU as a Get the latest Cellink AB (CLNK-B) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and Get offers and Know the prices of all Avanza variants and compare with other fonder, sparande och privatekonomi Avanza Bank AB Barclays Bank Plc Erik Penser Senaste nyheter om - CELLINK, aktieanalys, kursutveckling och rapporter.
Fordela

thai baht kurs idag
assemblin växjö sprinkler
e lagasse
hur mycket ska jag skatta på lönen
josefin sterky

Cellink AB (publ) (CLLKF) stock price prediction is 134.99973 USD. The Cellink AB (publ) stock forecast is 134.99973 USD for 2022 March 28, Monday; and 1088.043 USD for 2026 March 28, Saturday with technical analysis.

Files. IPO · Type. Price.